GlassScriptPhysician profile
Paul A Sabini
NPI 1669476164
$1,273.86
in general payments reported to CMS, 2019-2025
16 companies · $241 in 2025
The $241 reported for 2025 was less than what a typical Plastic Surgery Within The Head and Neck provider received nationally (typical 2025 total: $300).
See the full distribution for Plastic Surgery Within the Head and Neck
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $280 · 2021: $30.09 · 2022: $403 · 2023: $36.71 · 2024: $283 · 2025: $241.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $561.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $561.33 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Galderma Laboratories, L.P. | $503.06 | 2022-2025 | Dysport |
| Merz North America, INC. | $207.00 | 2022 | |
| Kerecis Limited | $143.47 | 2023-2025 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose, Kerecis Surgiclose |
| Abbvie INC. | $82.95 | 2019-2023 | Botox |
| Organogenesis INC. | $70.35 | 2022 | |
| Celgene Corporation | $41.40 | 2019 | |
| Sun Pharmaceutical Industries INC. | $35.55 | 2019 | |
| Regeneron Healthcare Solutions, INC. | $28.91 | 2019 | |
| Ucb, INC. | $26.88 | 2019 | |
| Mayne Pharma Commercial LLC | $25.01 | 2019 | |
| Medtronic, INC. | $23.54 | 2024 | V-Loc 180 |
| Lilly USA, LLC | $22.93 | 2019 | |
| Genzyme Corporation | $16.40 | 2019 | |
| Biofrontera INC. | $16.32 | 2019 | |
| Allergan, INC. | $16.28 | 2021 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Aerin Medical INC. | $13.81 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Paul Sabini listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.